Skip to content

Pharmacotherapy

ISSN 1875-9114

4 papers in the library · 42 citations · publishing 1996-2024

Papers

Sort Most recent Most cited

Intravenous ketamine successfully treats treatment-resistant catatonia in schizophrenia: A case report.

Pharmacotherapy October 1, 2024 Atif Siddiqui 5 citations

Benzodiazepines and electroconvulsive therapy (ECT) are mainstay treatments for catatonia, a potentially life-threatening psychomotor syndrome characterized by a range of symptoms, including immobility, mutism, stupor, posturing, and sometimes even agitation. It can be a manifestation of various underlying psychiatric or medical conditions, such as schizophrenia, mood disorders, or neurological...

Analysis of the psychoactive terpenoid salvinorin A content in five Salvia divinorum herbal products.

Pharmacotherapy September 1, 2006 William R Wolowich, Alisha M Perkins, John J Cienki 37 citations

To determine the content of the hallucinogen salvinorin A in a variety of Salvia divinorum herbal products and to compare the content with the label claims of potency and purity. Laboratory analysis. University-affiliated laboratory. Five herbal products containing Salvia divinorum. The samples were purchased from the Internet and local drug paraphernalia shops ("head shops"). Highperformance...

Putting an Ecstasy test kit to the test: harm reduction or harm induction?

Pharmacotherapy October 2003 Rebecca A Murray, Paul L Doering, Lisa A Boothby et al.

To evaluate the DanceSafe Complete Adulterant Screening Kit for Ecstasy with regard to its accuracy in identifying 3,4-methylenedioxymeth-amphetamine (MDMA) and methylenedioxyamphetamine (MDA) derivatives and its ability to detect certain contaminants. In part 1, 39 street-grade tablets purported to be MDMA were tested with the Marquis, Mecke, and Simon's reagents provided by the DanceSafe...

A Review of NMDA Receptors and the Phencyclidine Model of Schizophrenia

Pharmacotherapy January 2, 1996 Sheri A. Thornberg, S. R. Saklad

Current models of drug‐induced psychosis insufficiently describe the symptoms of schizophrenia. Phencyclidine‐induced psychosis is a model that more completely reflects the pathophysiology of the disease. By decreasing glutamatergic neurotransmission, phencyclidine decreases 7‐aminobutyric acid release from the nucleus accumbens, striatum, and hippocampus (manifested by MK‐801); may inhibit...